Research and Markets : View This Series of Charts Profiling Market Trends in Oncology Deal Making During 2000 to 2005

Research and Markets (http://www.researchandmarkets.com/reports/c20139) has announced the addition of Deals and Alliances Therapy Report: Oncology to their offering.

Dublin (PRWEB) July 3, 2005 -- Research and Markets (http://www.researchandmarkets.com/reports/c20139) has announced the addition of Deals and Alliances Therapy Report: Oncology to their offering.

This report provides a series of charts detailing market trends in oncology deal making over the period of 2000 to 2005.

Content includes the following:
Introduction
A summary of the deals and dealmakers over a five-year period. Includes charts and tables summarizing activity in the therapy area.

Deals by company
A comprehensive overview listing deals by company, with a full index of all the deals announced. A clear and easy way to see the activities of any company.

Deals by development stage
A review of deals by stage of development. Appreciate how deal values change from discovery to launch in the therapy area.

Summary profiles for the most active companies
Summary profiles for the most active companies in the therapy area over the past five years, including history, business strategy, partnering strategy, and deals listing.

List of deals
A full index of all the deals announced between May 2000 and April 2005. Entries contain financial information such as headline value, upfront and royalty rates, where available.

List of Charts
Fig. 1 Deal activity 2000-2005
Fig. 2 Deal activity last 12 months
Fig. 3 Deal activity in oncology by year
Fig. 4 Deal activity in oncology by type
Fig. 5 Deal activity in oncology by development stage

Who should read the report:
This report is essential reading for board and executive management, and individuals in:
-   business development
-   licensing/partnering
-   deal making   
-   business strategy
-   marketing and promotion
-   distribution and manufacturing (including contract services).

The report includes profiles from the following companies active in oncology:
Abbott Laboratories
Abgenix
AstraZeneca
Cancer Research Technology
Celgene
Corixa
Cytyc
Elan
Elekta
Genentech
GlaxoSmithKline
Hologic
ImmunoGen
Kirin Brewery
MD Anderson Cancer Center
Medarex
Memorial Sloan Kettering Cancer Center
Millennium Pharmaceuticals
National Cancer Institute
National Institutes of Health
R2 Technology
Roche
Seattle Genetics
TriPath Imaging
Viragen

Reasons to Read:
Deals and Alliances Therapy Report: Oncology provides a comprehensive summary of the deals and alliances announced in the field between May 2000 and April 2005, and helps in:
-identifying active partners
-tracking competitor activity
-benchmarking deals
-comparing the finances of different deal types

For more information visit http://www.researchandmarkets.com/reports/c20139

Laura Wood
Senior Manager
Research and Markets
press@researchandmarkets.com
Fax: +353 1 4100 980

###